Form D · Pharmaceuticals
Dolor Technologies LLC
South Jordan, UT · CIK 0001597094
Offering snapshot reported Jan 15, 2014 · SEC filing
- Reported sold
- $800K Offering amount: $1M
- Investors reported
- 3 Form D · investor count
- Minimum accepted
- $50K Reported outside-investor minimum
- First sale
- Dec 31, 2013 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jan 15, 2014 | Initial | $800,000 | No comparison | 3 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-210209
Source: Form D, filed Jan 15, 2014. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Corey Ericksen | Director |
| Richard Farnsworth | Director |
| Michael Marcum | Director |
| William Pipkin | Director |
| D.J. Poyfair | Director |
| Mark J. Wright | Executive |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
10967 Topview Road
South Jordan, UT, 84095
South Jordan, UT, 84095